Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MarketWatch

Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t.

Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t.
ShareXFacebook

Over the next year, countries that are home to 40% of the world’s population are set to get access to Ozempic and Wegovy generics that could cost as little as $15 a month.

M

Source

MarketWatch

Read full article at MarketWatch

Opens original article in a new tab

Advertisement

Related Economy Stories

EconomyDaily Composite
Bloomberg Markets

Odd Lots: Norman Foster on the Struggle to Build Big (Podcast)

Not many people think of designing buildings as an exercise in economics, but the entire process is defined by constraints around resources (both physical and financial), and an iconic building can also have a huge impact on the wealth and development of the area around it. So how do you encourage private developers to consider the public good when designing new projects? And how are some countries able to encourage more landmark building projects than others? In this episode, we speak with Norm

Read more →
Advertisement